|
About the Confirmatory Testing category -Please read before posting
|
|
1
|
701
|
March 30, 2025
|
|
N-Nitroso meglumine
|
|
26
|
1943
|
April 8, 2026
|
|
Nitrosamines: Mass Spectrometry-Based Analytical Procedures Criterias
|
|
7
|
4133
|
April 6, 2026
|
|
MDD for cream formulation
|
|
0
|
72
|
April 3, 2026
|
|
N-nitroso-Furosemide
|
|
2
|
448
|
March 31, 2026
|
|
Analysis method of cream
|
|
6
|
246
|
March 30, 2026
|
|
Optimized UHPLC–Derivatization Method for Low-Level Nitrite Detection in Pharmaceutical Excipients-Pub
|
|
0
|
183
|
March 23, 2026
|
|
How to Validate High-Resolution Mass Spectrometry for Nitrosamine Detection in Pharmaceuticals
|
|
3
|
344
|
March 21, 2026
|
|
Minimizing in Source Fragmentation for Mass Spectrometry Based NDSRI Analytical Procedures: A Case Study of Nitroso-bumetanide -Pub
|
|
4
|
298
|
March 19, 2026
|
|
Differences in Physical Form of Nitrosamine Reference Standards: USP vs. Other Suppliers
|
|
2
|
146
|
March 18, 2026
|
|
Scientific Clarification Request on Analytical Approach for Nitrosamine Determination in Quetiapine Oral Suspension
|
|
3
|
232
|
March 17, 2026
|
|
Challenges in developing an analytical method for N‑nitroso‑ambroxol -
|
|
1
|
141
|
March 14, 2026
|
|
Testing of N-nitroso-cinacalcet
|
|
8
|
996
|
March 14, 2026
|
|
N-Nitroso Metamizole Impurity C
|
|
3
|
249
|
March 12, 2026
|
|
Navigating the complexities in characterization of NDSRIs using advanced analytical techniques-Pub
|
|
2
|
231
|
March 12, 2026
|
|
Challenges in developing an analytical method for N‑nitroso‑ambroxol
|
|
3
|
200
|
March 11, 2026
|
|
Nitrosamine analysis in suspension dosage forms
|
|
5
|
253
|
March 6, 2026
|
|
N-Nitrosodibenzylamine infusion bags
|
|
0
|
114
|
February 27, 2026
|
|
Moxonidine Nitrosamines
|
|
6
|
271
|
February 25, 2026
|
|
N-nitroso-rivaroxaban amide
|
|
7
|
1932
|
February 4, 2026
|
|
Sufentanil Nitroso impurity standard
|
|
8
|
232
|
January 29, 2026
|
|
If NDSRIs are not detected at end of stability, is small-molecule nitrosamine testing still required?
|
|
5
|
251
|
January 23, 2026
|
|
Nitrosamine Impurities: The Analytical & Regulatory Roadmap (2024-2025)
|
|
0
|
384
|
January 20, 2026
|
|
Nitrosamines in macrocyclic antibiotics
|
|
2
|
236
|
December 10, 2025
|
|
Issue Regarding Purchase of N-Nitroso N-Desmethyl Rosuvastatin Reference Standard
|
|
5
|
259
|
December 10, 2025
|
|
Issue with Area Drop During N-Nitroso Dorzolamide Method Setup
|
|
3
|
206
|
December 10, 2025
|
|
N-Nitroso-Desmethyl-tetracycline MOA development
|
|
1
|
170
|
November 18, 2025
|
|
Determination of N-nitroso desmethyl Tetracycline
|
|
17
|
1106
|
October 27, 2025
|
|
N-Nitrosamine Quantitation in Pharmaceuticals by Tandem Mass Spectrometry
|
|
1
|
308
|
October 16, 2025
|
|
Method Validation
|
|
3
|
188
|
October 8, 2025
|